Ryan Bushey
Digital Editor

Ryan Bushey is a digital editor for Advantage Business Media’s Science Group.  He covers scientific discoveries, emerging technologies and the business of the life sciences sector for R&D Magazine and Drug Discovery & Development along with managing social media for both publications. He’s an experienced journalist whose work has appeared in Business Insider, Slate, and Indiewire.

A component of the common spice turmeric could be the key to killing treatment-resistant neuroblastoma tumor cells.
Digital Editor
|
7.26.2017
9:05am
The company’s clinical development program for this drug includes tests for over 30 tumor types in over 500 clinical trials.
Digital Editor
|
7.25.2017
10:43am
Proving this drug’s mechanism of action is viable could ultimately yield a multi-purpose therapy that could work for autoimmune conditions like lupus and...
Digital Editor
|
7.24.2017
1:37pm
Developing a potent therapy for Alzheimer’s disease will be one of the biggest healthcare challenges over the next few decades.
Digital Editor
|
7.21.2017
8:47am
The company's goal is to understand the link between infections, dysfunction of the gut’s enteric nervous system, and the early onset and chronic...
Digital Editor
|
7.20.2017
9:07am
Advertisement
The drugs are labeled VX-659, VX-152, and VX-440, respectively.
Digital Editor
|
7.19.2017
10:30am
This molecule serves as an integral multi-functioning ‘scaffolding’ protein vital to key functions of the brain.
Digital Editor
|
7.19.2017
10:10am
The 2017 International Society of Thrombosis and Hemostasis Congress was held July 8th through the 13th in Berlin, Germany.
Digital Editor
|
7.14.2017
10:32am
A breakthrough cancer treatment is one step closer to regulatory approval.
Digital Editor
|
7.13.2017
9:14am
Scientists have not been able to discern why this tissue becomes inflamed after trauma or infection until now.
Digital Editor
|
7.12.2017
9:43am
A division of the world’s largest food and drink company will launch a new startup focused on developing therapies for diseases associated with the microbiome.
Digital Editor
|
7.11.2017
10:36am
Implementing these new programs will fall under the framework of the 21st Century Cures Act.
Digital Editor
|
7.11.2017
8:54am
Cases of HF-PEF are expected to rise so this patient cohort could produce a lucrative opportunity for pharmaceutical companies.
Digital Editor
|
7.10.2017
11:08am
Advertisement
A new form of treatment for different types of cancer are showing signs of promise.
Digital Editor
|
7.7.2017
10:51am
The market for hemophilia treatments could see anemic growth over the next few years.
Digital Editor
|
7.6.2017
9:49am
Spinal muscular atrophy is a genetic condition characterized by loss of motor neurons in the spinal cord and lower brain stem inducing severe and progressive...
Digital Editor
|
7.5.2017
9:17am
This continues a trend where prominent drug makers are exploring new technologies in the digital health space.
Digital Editor
|
7.3.2017
10:55am
An experimental study may yield a new alternative for receiving annual vaccinations against the influenza virus.
Digital Editor
|
6.29.2017
10:19am
The comedian is no stranger to criticizing the pharmaceutical industry, but he took a different route this week.
Digital Editor
|
6.27.2017
3:20pm
Sarepta Therapeutics is expanding its arsenal of drug development initiatives.
Digital Editor
|
6.23.2017
8:00am
One of the top life science oriented venture capital firms unveiled the latest addition to its portfolio.
Digital Editor
|
6.21.2017
2:28pm
Advertisement
Nelotanserin is being designed to target the 5HT2A receptor.
Digital Editor
|
6.20.2017
11:49am
The legislation focuses on manufacturers of diabetes treatments and pharmacy benefits managers.
Digital Editor
|
6.16.2017
10:17am
One of the top life science focused venture capital firms is continuing an ambitious hiring spree.
Digital Editor
|
6.15.2017
10:26am
Novo’s insulin product is a once-daily long-acting form of the diabetes treatment.
Digital Editor
|
6.14.2017
8:00am
Two prominent pharmaceutical firms from overseas released promising new findings that could stave off low blood sugar.
Digital Editor
|
6.13.2017
10:04am
The DACRAS platform includes multiple molecules, but the prominent ones include KBP-042, KBP-089 and KBP-056.
Digital Editor
|
6.9.2017
10:10am
More than 30,000 oncologists recently attended the annual American Society for Clinical Oncology meeting held in Chicago.
Digital Editor
|
6.8.2017
8:45am
Roche is gaining ground in the lung cancer treatment space.
Digital Editor
|
6.6.2017
11:35am
J&J unveiled new late-stage data on Saturday at the annual American Society for Clinical Oncology meeting for abiraterone acetate.
Digital Editor
|
6.5.2017
12:36pm
The report provides a snapshot of the progress made in the fight against these diseases.
Digital Editor
|
6.2.2017
9:09am
The Israeli drug company could gain an edge in the migraine treatment space due to new clinical data.
Digital Editor
|
6.1.2017
8:50am
Overall, the drug was able to improve patients’ conditions and helped more individuals become seizure-free than placebo.
Digital Editor
|
5.25.2017
10:12am
The trial is supported by the HIV Vaccines Trial Network (HVTN) and the National Institute of Allergy and Infectious Diseases (NIAID).
Digital Editor
|
5.25.2017
10:11am
An experimental osteoporosis drug being developed by Amgen and UCB produced surprising safety data in this evaluation.
Digital Editor
|
5.22.2017
11:16am
Investigators gave 125 patients 150 or 300 mg subcutaneously administered dosages every four weeks or 300 mg every two weeks.
Digital Editor
|
5.19.2017
11:11am
The healthcare giant’s pharmaceutical unit intends to launch or file for regulatory approval more than 10 novel therapies with blockbuster potential between...
Digital Editor
|
5.17.2017
10:40am
Scott Gottlieb was a physician-turned-health consultant who previously served as deputy commissioner of the FDA under the George W. Bush administration.
Digital Editor
|
5.16.2017
11:12am
The company will pay $120 million to Remedy Pharmaceuticals, the original developer of the drug.
Digital Editor
|
5.15.2017
11:19am